Michael Somers, MD

Boston Children's Hospital
Boston, Massachusetts, United States

Presentation(s):

• Kidney Function and Isolated Kidney Transplant Outcomes in Primary Hyperoxaluria Type 1 Treated with Long-term Lumasiran

  Sunday, April 27, 2025
  2:30pm – 2:45pm HST

  Disclosure(s): Alnylam Pharmaceuticals (Ongoing) (Products/Services: Consultant); Dicerna Pharmaceuticals (Ongoing) (Products/Services: Consultant); Novo Nordisk (Ongoing) (Products/Services: Advisory Committee)